Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications.
about
Filling the gap in CNS drug development: evaluation of the role of drug repurposing.Drug repurposing in oncology--patient and health systems opportunities.Unlocking the potential of established products: toward new incentives rewarding innovation in Europe.The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children
P2860
Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Drug reformulations and reposi ...... cess: regulatory implications.
@en
type
label
Drug reformulations and reposi ...... cess: regulatory implications.
@en
prefLabel
Drug reformulations and reposi ...... cess: regulatory implications.
@en
P2093
P2860
P356
P1476
Drug reformulations and reposi ...... cess: regulatory implications.
@en
P2093
Aurélie Millier
Michel Lamure
Susana Murteira
Zied Ghezaiel
P2860
P356
10.3402/JMAHP.V2.22813
P577
2014-01-29T00:00:00Z